SVRA vs REGN: Which Stock is Better?
Side-by-side comparison of Savara Inc and Regeneron Pharmaceuticals Inc in 2026
SVRA
Savara Inc
$5.78
REGN
Regeneron Pharmaceuticals Inc
$750.57
Key Metrics Comparison
| Metric | SVRA | REGN | Winner |
|---|---|---|---|
| Market Cap | $1.18B | $79.35B | REGN |
| P/E Ratio | N/A | 18.08 | REGN |
| EPS (TTM) | $N/A | $41.51 | REGN |
| Revenue Growth | 0.0% | 0.0% | REGN |
| Gross Margin | -8140400.0% | 44.6% | REGN |
Analyze SVRA
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is SVRA or REGN a better investment?
Comparing SVRA and REGN: Savara Inc has a market cap of $1.18B while Regeneron Pharmaceuticals Inc has $79.35B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between SVRA and REGN?
SVRA (Savara Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: SVRA or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: SVRA or REGN?
REGN has higher revenue growth at 0.0% vs 0.0% for SVRA.
Which company is more profitable: SVRA or REGN?
Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to -8140400.0% for SVRA.
Which is the larger company: SVRA or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.35B compared to $1.18B for SVRA.
Should I buy SVRA or REGN in 2026?
Both SVRA and REGN have investment merit. SVRA trades at $5.78 while REGN trades at $750.57. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between SVRA and REGN stock?
Key differences: Market Cap ($1.18B vs $79.35B), P/E Ratio (N/A vs 18.1x), Revenue Growth (0.0% vs 0.0%), Gross Margin (-8140400.0% vs 44.6%).